中国医疗设备2025，Vol.40Issue(5)：17-23,41,8.DOI:10.3969/j.issn.1674-1633.20241526
组织工程与再生医学领域临床试验竞争格局分析
Competitive Landscape Analysis of Clinical Trials in Tissue Engineering and Regenerative Medicine
摘要
Abstract
Objective To analyze clinical trial data in the field of tissue engineering and regenerative medicine from ClinicalTrials.gov and the Chinese Clinical Trial Registry(ChiCTR)to present the global and Chinese competitive landscape.Methods Data on clinical trials in the field of tissue engineering and regenerative medicine were collected from the two databases.A bibliometric analysis was conducted based on the number of registrations,countries or cities,clinical trial institutions,and sponsors.Results Based on ClinicalTrials.gov data,there were 582 registered clinical trials globally in the field of tissue engineering and regenerative medicine.Among 60 countries,the United States had 233 trials,China had 71,and all other countries had fewer than 30.Among more than 2000 clinical trial institutions,institutions such as Columbia University and University of California,Los Angeles in the United States stood out.Among 305 sponsors,55.74%were universities/hospitals,and 27.54%were enterprises.122 sponsors in the United States conducted 269 clinical trials,showing high activity.Based on ChiCTR data,China registered 97 clinical trials in this field.Among 29 cities,Shanghai registered 40 trials,Beijing registered 26,and other cities registered fewer than 10 trials.Among 76 clinical trial institutions and 45 sponsors,Beijing and Shanghai had the largest numbers,with institutions like Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine and Peking University School and Hospital of Stomatology being highly involved.Conclusion The number of registered clinical trials in the field of tissue engineering and regenerative medicine is on the rise globally and in China.The United States is in the leading position.There is still a gap between China and the United States,and international multi-center cooperation needs to be strengthened.关键词
组织工程与再生医学/细胞修复/人工器官/ClinicalTrials.gov/中国临床试验注册中心/文献计量分析Key words
tissue engineering and regenerative medicine/cell repair/artificial organ/ClinicalTrials.gov/Chinese Clinical Trial Registry/bibliometric analysis分类
基础医学引用本文复制引用
卢岩,王建波,陈娟,欧阳昭连..组织工程与再生医学领域临床试验竞争格局分析[J].中国医疗设备,2025,40(5):17-23,41,8.基金项目
中国医学科学院医学与健康科技创新工程"医学知识管理与智能化知识服务关键技术研究"(2021-I2M-1-056) （2021-I2M-1-056）
国家自然科学基金(L1924064) （L1924064）
深圳市卫生健康发展研究和数据管理中心"组织工程与再生医学专题报告项目"(sz20240119). （sz20240119）
